Experimentally induced metabolic acidosis in rabbits modulates the interaction of aortic glycosaminoglycan with plasma low-density lipoprotein-An interesting observation about the association of acidosis and atherosclerosis

Atherosclerosis

Volumn 192, Issue 1, 2007, Pages 33-39

  Tovar, Ana M F ^a   Pecly, Inah M D ^a   Rangel, Ednei P ^b   Melo Filho, Nelson M ^a   Mourão, Paulo A S ^a   Leite Jr , Maurilo ^b  

^a Clementino Fraga Filho Universitary Hospital   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Acidosis; Atherosclerosis; Glycosaminoglycan; LDL

Indexed keywords

GLYCOSAMINOGLYCAN; LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL DIET; COMPLEX FORMATION; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE MODEL; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC ACIDOSIS; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RABBIT; THORACIC AORTA;

ACIDOSIS, LACTIC; ANIMALS; AORTA, THORACIC; ATHEROSCLEROSIS; CHOLESTEROL, LDL; DISEASE MODELS, ANIMAL; GLYCOSAMINOGLYCANS; MALE; RABBITS;

EID: 34247158628     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.06.011     Document Type: Article

References (29)

1. Williams K., and Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15 (1995) 551-561
2. Camejo G., Hurt-Camejo E., Wiklund O., and Bondjers G. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis 139 (1998) 205-222
3. Srinivasan S.R., Radhakrishnamurthy B., Vijayagopal P., and Berenson G.S. Proteoglycans, lipoproteins, and atherosclerosis. Adv Exp Med Biol 285 (1991) 373-381
4. Wagner W.D., Edwards I.J., St Clair R.W., and Barakat H. Low density lipoprotein interaction with artery derived proteoglycan: the influence of LDL particle size and the relationship to atherosclerosis susceptibility. Atherosclerosis 75 (1989) 49-59
5. Skalen K., Gustafsson M., Rydberg E.K., Hulten L.M., Wiklund O., Innerarity T.L., et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417 (2002) 750-754
6. Li H., Reddick R.L., and Maeda N. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice. Arterioscler Thromb 13 (1993) 1814-1821
7. Mills G.L., and Taylaur C.E. The distribution and composition of serum lipoproteins in 18 animals. Comp Biochem Physiol [B] 40 (1971) 489-501
8. Brown M.S., and Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 232 (1986) 34-47
9. Kahn J.A., and Glueck C.J. Familial hypobetalipoproteinemia: absence of atherosclerosis in a postmortem study. JAMA 240 (1978) 47-48
10. Kalantar-Zadeh K., Stenvinkel P., Pillon L., and Kopple J.D. Inflammation and nutrition in renal insufficiency. Adv Ren Replace Ther 10 (2003) 155-169
11. Pecoits-Filho R., Lindholm B., and Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome-the heart of the matter. Nephrol Dial Transplant 17 Suppl 11 (2002) 28-31
12. Amann K., Tyralla K., Gross M.L., Eifert T., Adamczak M., and Ritz E. Special characteristics of atherosclerosis in chronic renal failure. Clin Nephrol 60 Suppl 1 (2003) 13-21
13. Charney D.I., Walton D.F., and Cheung A.K. Atherosclerosis in chronic renal failure. Curr Opin Nephrol Hypertens 2 (1993) 876-882
14. Morgan J., and Leake D.S. Acidic pH increases the oxidation of LDL by macrophages. FEBS Lett 333 (1993) 275-279
15. Lamb D.J., and Leake D.S. Iron released from transferrin at acidic pH can catalyse the oxidation of low density lipoprotein. FEBS Lett 352 (1994) 15-18
16. Leake D.S. Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions?. Atherosclerosis 129 2 (1997) 149-157
17. Bitter T., and Muir H.M. A modified uronic acid carbazole reaction. Anal Biochem 4 (1962) 330-334
18. Havel R.J., Eder H.A., and Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34 (1955) 1345-1353
19. Castro M.G., Spruce B.A., Savva D., and Lowry P.J. Expression of biologically active human pre-procorticotropin releasing hormone in E. coli: characterization and purification. Int J Biochem 22 11 (1990) 1341-1349
20. Mourão P.A.S., and Bracamonte C. The binding of human aortic glycosaminoglycans and proteoglycans to plasma low density lipoprotein. Atherosclerosis 50 (1984) 133-146
21. Tovar A.M.F., and Mourão P.A.S. High affinity of a fucosylated chondroitin sulfate for plasma low density lipoprotein. Atherosclerosis 126 (1996) 185-195
22. Vijayagopal P., Srinivasan S.R., Radhakrishnamurthy B., and Berenson G.S. Interaction of serum lipoproteins and a proteoglycan from bovine aorta. J Biol Chem 256 (1981) 8234-8241
23. Cardoso L.E.M., and Mourão P.A.S. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Artherioscler Thromb 14 (1994) 115-124
24. Tovar A.M., Cesar D.C., Leta G.C., and Mourão P.A.S. Age-related changes in populations of aortic glycosaminoglycans: species with low-affinity for plasma low-density lipoproteins, and not species with high affinity, are preferentially affected. Arterioscler Thromb Vasc Biol 18 (1998) 604-614
25. Haas M.J., Reinacher D., Li J.P., Wong N.C., and Moorandian A.D. Regulation of apoA1 gene expression with acidosis: requirement for a transcriptional repressor. J Mol Endocrinol 27 (2001) 43-57
26. Shirk R.A., Parthasarathy N., San Antonio J.D., Church F.C., and Wagner W.D. Altered dermatan sulfate structure and reduced heparin cofactor II stimulating activity of biglycan and decorin from human atherosclerotic plaque. J Biol Chem 275 (2000) 18085-18092
27. Camejo G., Fager G., Rosengren B., Hurt-Camejo E., and Bondjers G. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem 268 (1993) 14131-14137
28. Nigro J., Ballinger M.L., Dilley R.J., Jennings G.L.R., Wight T.N., and Little P.J. Fenofibrate modifies human vascular smooth muscle proteoglycans and reduces lipoprotein binding. Diabetologia 47 (2004) 2105-2113
29. Lindholm M.W., Nilsson J., and Moses J. Low density lipoprotein stimulation of human macrophage proteoglycan secretion. Biochem Biophys Res Commun 328 2 (2005) 455-460